Celestica, Inc. $CLS Shares Bought by Amundi

Key Points

• Amundi increased its Celestica stake by 49.5% in the second quarter, purchasing 105,752 additional shares and bringing its holdings to 319,304 shares valued at approximately $116.5 million. Institutional investors collectively own 67.38% of the company.
• Celestica exceeded quarterly expectations, reporting $2.54 in EPS on $4.68 billion in revenue, with revenue up 62.4% year over year. The company forecast third-quarter 2026 EPS of $2.88–$3.08.
• Analyst sentiment remains positive, with a consensus “Buy” rating and an average price target of $439.81, although insiders sold approximately $135.2 million of shares over the past 90 days.

Amundi increased its stake in Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS by 49.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 319,304 shares of the technology company's stock after acquiring an additional 105,752 shares during the quarter. Amundi owned approximately 0.28% of Celestica worth $116,501,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its holdings in shares of Celestica by 24.8% during the 4th quarter. JPMorgan Chase & Co. now owns 4,017,623 shares of the technology company's stock worth $1,187,650,000 after acquiring an additional 798,782 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in Celestica by 5,806,149.2% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,657,937 shares of the technology company's stock valued at $1,081,323,000 after acquiring an additional 3,657,874 shares during the last quarter. Franklin Resources Inc. lifted its holdings in Celestica by 18.6% in the fourth quarter. Franklin Resources Inc. now owns 2,278,214 shares of the technology company's stock valued at $673,471,000 after acquiring an additional 356,797 shares during the last quarter. Cibc World Market Inc. grew its position in Celestica by 30.6% in the fourth quarter. Cibc World Market Inc. now owns 2,265,680 shares of the technology company's stock worth $670,279,000 after acquiring an additional 530,535 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Celestica during the 2nd quarter worth $674,199,000. 67.38% of the stock is owned by hedge funds and other institutional investors.

Celestica Price Performance

Shares of NYSE CLS opened at $333.38 on Thursday. The stock has a fifty day moving average price of $325.59 and a 200 day moving average price of $336.91. Celestica, Inc. has a 1-year low of $227.00 and a 1-year high of $474.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.23 and a quick ratio of 0.68. The company has a market cap of $38.33 billion, a PE ratio of 34.65 and a beta of 2.04.

Celestica (NYSE:CLS - Get Free Report) TSE: CLS last posted its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share for the quarter, topping analysts' consensus estimates of $2.29 by $0.25. Celestica had a net margin of 7.16% and a return on equity of 39.96%. The business had revenue of $4.68 billion for the quarter, compared to analysts' expectations of $4.30 billion. During the same period in the prior year, the company posted $1.39 EPS. The business's revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Sell-side analysts forecast that Celestica, Inc. will post 10.71 EPS for the current year.

Wall Street Analyst Weigh In

CLS has been the topic of several research reports. Wall Street Zen lowered Celestica from a "buy" rating to a "hold" rating in a research note on Sunday. Zacks Research raised shares of Celestica from a "hold" rating to a "strong-buy" rating in a research report on Friday, June 26th. Wolfe Research raised their price objective on shares of Celestica from $425.00 to $475.00 and gave the company an "outperform" rating in a research note on Wednesday, July 29th. UBS Group upgraded shares of Celestica from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $410.00 to $430.00 in a report on Monday, August 24th. Finally, Royal Bank Of Canada set a $450.00 target price on shares of Celestica and gave the stock an "outperform" rating in a research note on Wednesday, August 26th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $439.81.

Insider Buying and Selling at Celestica

In other news, CEO Robert Mionis sold 98,453 shares of the company's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total value of $36,328,172.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Mandeep Chawla sold 17,000 shares of the firm's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $399.65, for a total value of $6,794,050.00. Following the sale, the chief financial officer owned 82,444 shares of the company's stock, valued at $32,948,744.60. This represents a 17.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 356,553 shares of company stock worth $135,238,444 over the last ninety days. Corporate insiders own 1.10% of the company's stock.

Celestica Company Profile

Celestica Inc NYSE: CLS is a global provider of design, manufacturing, and supply chain solutions for technology companies and other businesses. The company helps customers develop, manufacture, and support complex electronic products and systems, offering services that span product design and engineering, prototyping, printed circuit board assembly, systems integration, testing, supply chain management, and after-market support.

Celestica serves customers across several markets, including communications and cloud infrastructure, aerospace and defense, industrial technology, health technology, and capital equipment.

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS - Free Report) TSE: CLS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.